Although limited, prior reports indicate that a subset of the predicted targets (e.g. ATM, UBE2I, APEX, ADAM1, BUB1B, PAK2, PRMT5) are involved in ACC pathogenesis (Supplementary Table 6), supporting the validity of our predictive discovery pipeline. This evidence concerns the gene ADAM1A and adrenal cortex carcinoma.